Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Tackling unexpected financial costs starts with a clear plan and small, steady changes you can implement today.
24,369 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
Nvidia powers the AI era, but is its stock a smart buy right now? This guide breaks down the fundamentals, compares c...
When markets stumble, strong AI leaders can offer both stability and growth. This guide highlights five AI-driven sto...
New data reveals a recurring pattern: bitcoin traders dump coins in the 48 hours after FED policy decisions, marking ...
Crypto traders are watching SpaceX’s near-public listing for signs that pre-IPO perpetual futures could become a majo...
Emerging renders point to a major Siri refresh: a standalone app, deeper Dynamic Island integration, and a Gemini-bas...
Strategy’s flagship STRC yield product slid to yearly lows as Bitcoin volatility intensified, weighing on the company...
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...